`
`
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`INITIATIVE FOR MEDICINES, ACCESS & KNOWLEDGE (I-MAK), INC.
`Petitioner
`
`v.
`
`GILEAD PHARMASSET LLC
`Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2018-00125
`Patent 8,633,309
`
`
`
`
`
`
`
`
`
`
`
`
`PATENT OWNER GILEAD PHARMASSET LLC’S
`MANDATORY NOTICES
`
`
`
`ActiveUS 165461518v.1
`
`
`
`Case IPR2018-00125
`Attorney Docket No: 2209539-00142
`
`
`
`
`
`PATENT OWNER’S MANDATORY NOTICES
`UNDER 37 C.F.R. § 42.8
`
`Pursuant to 37 C.F.R. § 42.8, the patent owner, Gilead Pharmasset LLC
`
`(“Patent Owner”), hereby submits the following Mandatory Notices in response to
`
`the Petition for Inter Partes Review of U.S. Patent No. 8,633,309.
`
`1.
`
`Real Party-In-Interest under 37 CFR § 42.8(b)(1)
`
`Gilead Pharmasset LLC is the Patent Owner and Gilead, Inc. is a Real Party-
`
`In-Interest in this proceeding.
`
`2.
`
`Related Matters under 37 CFR § 42.8(b)(2)
`
`The following judicial or administrative matters may affect or be affected by
`
`a decision in this proceeding:
`
`U.S. Patent Application Serial No. 12/783,680 filed 05/20/2010 (Now U.S.
`
`Patent No. 8,642,756), U.S. Patent Application Serial No. 13/732,725 filed
`
`01/02/2013 (Now U.S. Patent No. 9,206,217), U.S. Patent Application Serial No.
`
`14/152,243 filed 01/10/2014 (Now U.S. Patent No. 9,637,512), U.S. Patent
`
`Application Serial No. 15/471,128 filed 03/28/2017 (Pending), U.S. Patent
`
`Application Serial No. 13/750,474 filed 01/25/2013 (Now Patent No. 8,629,263),
`
`U.S. Patent Application Serial No. 13/076,552 filed 03/31/2011 (Now U.S. Patent
`
`No. 8,618,076) and U.S. Patent Application Serial No. 13/936,448 filed
`
`07/08/2013 (Now U.S. Patent No. 8,735,569), U.S. Patent Application Serial No.
`2
`
`ActiveUS 165461518v.1
`
`
`
`Case IPR2018-00125
`Attorney Docket No: 2209539-00142
`13/076,718 filed 03/31/2011 (Now U.S. Patent No. 8,563,530), U.S. Patent
`
`Application Serial No. 13/076,842 filed 03/31/2011 (Now Patent No. 8,859,756),
`
`U.S. Patent Application Serial No. 13/925,078 filed 06/24/2013 (Now Patent
`
`Number 9,284,342) and U.S. Patent Application Serial No. 15/016,828 filed
`
`02/05/2016 (Pending).
`
`Patent Owner notes that Petitioner filed two petitions for Inter Partes Review
`
`of U.S. Patent No. 7,964,580 (Case Nos. IPR2018-00119 and IPR2018-00120);
`
`two petitions for Inter Partes Review of U.S. Patent No. 8,334,270 (Case Nos.
`
`IPR2018-00121 and IPR2018-00122), one petition for Inter Partes Review of U.S.
`
`Patent 7,429,572 (Case IPR2018-00103), and one petition for Inter Partes Review
`
`of U.S. Patent No. 9,284,342 (Case No. IPR2018-00126).
`
`Patent Owner does not concede that any of the above-identified patents,
`
`applications, or proceedings, aside from U.S. Patent No. 3,633,309 would affect, or
`
`be affected by this proceeding.
`
`3.
`
`Lead and Back-Up Counsel, under 37 CFR § 42.8(b)(3)
`
`The Patent Owner designates the following lead and back-up counsel:
`
`LEAD COUNSEL
`David L. Cavanaugh, Reg. No. 36,476
`1875 Pennsylvania Avenue, N.W.
`Washington, DC 20006
`Phone: 202 663 6025
`Fax: 202 663 6363
`Email:
`
`BACK-UP COUNSEL
`Emily R. Whelan, Reg. No. 50,391
`60 State Street
`Boston MA 02109
`Phone 617 526 6567
`Fax: 617 526 5000
`Email: emily.whelan@wilmerhale.
`3
`
`ActiveUS 165461518v.1
`
`
`
`david.cavanaugh@wilmerhale.com
`
`
`
`
`
`
`
`4.
`
`Case IPR2018-00125
`Attorney Docket No: 2209539-00142
`
`
`Dorothy P. Whelan, Reg. No. 33,814
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (612) 337-2509
`Email:
` PTABInbound@fr.com
`Fax:
`
`(612) 288-9696
`
`
`Michael J. Kane, Reg. No. 39,722
` 3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (612) 337-2502
`Email:
`PTABInbound@fr.com
`Fax:
`
`(612) 288-9696
`
`W. Chad Shear, Reg. No. 47,938
` 3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (858) 678-4730
`Email:
`PTABInbound@fr.com
`Fax:
`
`(612) 288-9696
`
`Service Information under 37 CFR § 42.8(b)(4)(i) et seq.
`
`Please address all correspondence and service to both counsel as listed
`
`above. Patent Owner consents to service by email to the email addresses above
`
`(ref.: Docket No. 2209539-00137; Case IPR2018-00125).
`
`
`
`
`
`
`
`
`
`
`
`
`
`4
`
`ActiveUS 165461518v.1
`
`
`
`Case IPR2018-00125
`Attorney Docket No: 2209539-00142
`
`
`
`
`
`
`
`
`
`
`
`
`
` Respectfully submitted,
`
`
`
`
`Date: November 9, 2017
`
`
`Customer Number 24395
`Wilmer, Cutler, Pickering, Hale and Dorr, LLP
`Phone 202 663 6000
`
`
`
`
`
`
`
`/David L. Cavanaugh/
`David L. Cavanaugh
`Reg. No. 36,476
`
`ActiveUS 165461518v.1
`
`5
`
`
`
`Case IPR2018-00125
`Attorney Docket No: 2209539-00142
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR §§ 42.6(e)(4) and 42.205(b), the undersigned certifies
`
`that on November 9, 2017, a complete and entire copy of this Patent Owner Gilead
`
`Pharmasset LLC’s Mandatory Notices and Power of Attorney were provided via
`
`electronic service, to the Petitioner by serving the correspondence address of
`
`record as follows:
`
`Daniel B. Ravicher
`Ravicher Law Firm PLLC
`2000 Ponce De Leon Blvd Ste 600
`Coral Gables, FL 33134
`
`E-mail: dan@ravicher.com
`
`/David L. Cavanaugh/
`David L. Cavanaugh, Reg. No. 36,476
`1875 Pennsylvania Avenue, N.W.
`Washington, DC 20006
`Phone: 202 663 6025
`
`ActiveUS 165461518v.1
`
`6
`
`